These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 17906881)

  • 1. Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease.
    Hehr U; Uyanik G; Gross C; Walter MC; Bohring A; Cohen M; Oehl-Jaschkowitz B; Bird LM; Shamdeen GM; Bogdahn U; Schuierer G; Topaloglu H; Aigner L; Lochmüller H; Winkler J
    Neurogenetics; 2007 Nov; 8(4):279-88. PubMed ID: 17906881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease.
    Manya H; Sakai K; Kobayashi K; Taniguchi K; Kawakita M; Toda T; Endo T
    Biochem Biophys Res Commun; 2003 Jun; 306(1):93-7. PubMed ID: 12788071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical spectrum of muscle-eye-brain disease: from the typical presentation to severe autistic features.
    Haliloglu G; Gross C; Senbil N; Talim B; Hehr U; Uyanik G; Winkler J; Topaloglu H
    Acta Myol; 2004 Dec; 23(3):137-9. PubMed ID: 15938569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease.
    Taniguchi K; Kobayashi K; Saito K; Yamanouchi H; Ohnuma A; Hayashi YK; Manya H; Jin DK; Lee M; Parano E; Falsaperla R; Pavone P; Van Coster R; Talim B; Steinbrecher A; Straub V; Nishino I; Topaloglu H; Voit T; Endo T; Toda T
    Hum Mol Genet; 2003 Mar; 12(5):527-34. PubMed ID: 12588800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel POMGnT1 mutations cause muscle-eye-brain disease in Chinese patients.
    Jiao H; Manya H; Wang S; Zhang Y; Li X; Xiao J; Yang Y; Kobayashi K; Toda T; Endo T; Wu X; Xiong H
    Mol Genet Genomics; 2013 Aug; 288(7-8):297-308. PubMed ID: 23689641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan.
    Godfrey C; Clement E; Mein R; Brockington M; Smith J; Talim B; Straub V; Robb S; Quinlivan R; Feng L; Jimenez-Mallebrera C; Mercuri E; Manzur AY; Kinali M; Torelli S; Brown SC; Sewry CA; Bushby K; Topaloglu H; North K; Abbs S; Muntoni F
    Brain; 2007 Oct; 130(Pt 10):2725-35. PubMed ID: 17878207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cobblestone lissencephaly: neuropathological subtypes and correlations with genes of dystroglycanopathies.
    Devisme L; Bouchet C; Gonzalès M; Alanio E; Bazin A; Bessières B; Bigi N; Blanchet P; Bonneau D; Bonnières M; Bucourt M; Carles D; Clarisse B; Delahaye S; Fallet-Bianco C; Figarella-Branger D; Gaillard D; Gasser B; Delezoide AL; Guimiot F; Joubert M; Laurent N; Laquerrière A; Liprandi A; Loget P; Marcorelles P; Martinovic J; Menez F; Patrier S; Pelluard F; Perez MJ; Rouleau C; Triau S; Attié-Bitach T; Vuillaumier-Barrot S; Seta N; Encha-Razavi F
    Brain; 2012 Feb; 135(Pt 2):469-82. PubMed ID: 22323514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic diagnostic test for Muscle-Eye-Brain type congenital muscular dystrophy using commercially available reagents.
    Zhang W; Vajsar J; Cao P; Breningstall G; Diesen C; Dobyns W; Herrmann R; Lehesjoki AE; Steinbrecher A; Talim B; Toda T; Topaloglu H; Voit T; Schachter H
    Clin Biochem; 2003 Jul; 36(5):339-44. PubMed ID: 12849864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe muscle-eye-brain disease is associated with a homozygous mutation in the POMGnT1 gene.
    Teber S; Sezer T; Kafali M; Manzini MC; Konuk Yüksel B; Tekin M; Fitöz S; Walsh CA; Deda G
    Eur J Paediatr Neurol; 2008 Mar; 12(2):133-6. PubMed ID: 17881266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.
    Yoshida A; Kobayashi K; Manya H; Taniguchi K; Kano H; Mizuno M; Inazu T; Mitsuhashi H; Takahashi S; Takeuchi M; Herrmann R; Straub V; Talim B; Voit T; Topaloglu H; Toda T; Endo T
    Dev Cell; 2001 Nov; 1(5):717-24. PubMed ID: 11709191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic spectrum of Fukutinopathy: most severe phenotype of Fukutinopathy.
    Yoshioka M
    Brain Dev; 2009 Jun; 31(6):419-22. PubMed ID: 18834683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fukutin mutations in non-Japanese patients with congenital muscular dystrophy: less severe mutations predominate in patients with a non-Walker-Warburg phenotype.
    Yis U; Uyanik G; Heck PB; Smitka M; Nobel H; Ebinger F; Dirik E; Feng L; Kurul SH; Brocke K; Unalp A; Özer E; Cakmakci H; Sewry C; Cirak S; Muntoni F; Hehr U; Morris-Rosendahl DJ
    Neuromuscul Disord; 2011 Jan; 21(1):20-30. PubMed ID: 20961758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant.
    Clement EM; Godfrey C; Tan J; Brockington M; Torelli S; Feng L; Brown SC; Jimenez-Mallebrera C; Sewry CA; Longman C; Mein R; Abbs S; Vajsar J; Schachter H; Muntoni F
    Arch Neurol; 2008 Jan; 65(1):137-41. PubMed ID: 18195152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain involvement in muscular dystrophies with defective dystroglycan glycosylation.
    Clement E; Mercuri E; Godfrey C; Smith J; Robb S; Kinali M; Straub V; Bushby K; Manzur A; Talim B; Cowan F; Quinlivan R; Klein A; Longman C; McWilliam R; Topaloglu H; Mein R; Abbs S; North K; Barkovich AJ; Rutherford M; Muntoni F
    Ann Neurol; 2008 Nov; 64(5):573-82. PubMed ID: 19067344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual presentation of muscle-eye-brain disease: severe eye abnormalities with mild muscle and brain involvement.
    Demir E; Gucuyener K; Akturk A; Talim B; Konus O; Del Bo R; Ghezzi S; Comi GP
    Neuromuscul Disord; 2009 Oct; 19(10):692-5. PubMed ID: 19679478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. POMGnT1 mutations in congenital muscular dystrophy: genotype-phenotype correlation and expanded clinical spectrum.
    Biancheri R; Bertini E; Falace A; Pedemonte M; Rossi A; D'Amico A; Scapolan S; Bergamino L; Petrini S; Cassandrini D; Broda P; Manfredi M; Zara F; Santorelli FM; Minetti C; Bruno C
    Arch Neurol; 2006 Oct; 63(10):1491-5. PubMed ID: 17030669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fukutin and alpha-dystroglycanopathies.
    Toda T; Chiyonobu T; Xiong H; Tachikawa M; Kobayashi K; Manya H; Takeda S; Taniguchi M; Kurahashi H; Endo T
    Acta Myol; 2005 Oct; 24(2):60-3. PubMed ID: 16550916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, radiological, and genetic survey of patients with muscle-eye-brain disease caused by mutations in POMGNT1.
    Yiş U; Uyanik G; Rosendahl DM; Carman KB; Bayram E; Heise M; Cömertpay G; Kurul SH
    Pediatr Neurol; 2014 May; 50(5):491-7. PubMed ID: 24731844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genetic model for muscle-eye-brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1).
    Liu J; Ball SL; Yang Y; Mei P; Zhang L; Shi H; Kaminski HJ; Lemmon VP; Hu H
    Mech Dev; 2006 Mar; 123(3):228-40. PubMed ID: 16458488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biallelic Mutations in TMTC3, Encoding a Transmembrane and TPR-Containing Protein, Lead to Cobblestone Lissencephaly.
    Jerber J; Zaki MS; Al-Aama JY; Rosti RO; Ben-Omran T; Dikoglu E; Silhavy JL; Caglar C; Musaev D; Albrecht B; Campbell KP; Willer T; Almuriekhi M; Çağlayan AO; Vajsar J; Bilgüvar K; Ogur G; Abou Jamra R; Günel M; Gleeson JG
    Am J Hum Genet; 2016 Nov; 99(5):1181-1189. PubMed ID: 27773428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.